The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Image in cardiology

First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve

EuroIntervention 2014;9:1368 published online ahead of print February 2014. DOI: 10.4244/EIJV9I11A229

1. Department of Cardiology, University Hospital Basel, Basel, Switzerland; 2. The Heart Centre, Royal Victoria Hospital, Belfast, United Kingdom
A 79-year-old woman was admitted with dyspnoea NYHA Class III to IV. Five years previously, she had undergone surgical aortic valve replacement (Mitroflow® 19 mm; Sorin S.p.A., Milan, Italy). Transthoracic echocardiography revealed a degenerated bioprosthesis (area 225.7 mm2, perimeter 53.4 mm, area and perimeter derived diameter 17 mm; Figure 1A, Figure 1B) with a severe stenosis (aortic valve area 0.63 cm2), a severe transvalvular and mild paravalvular regurgitation, and a severely reduced left ventricular ejection fraction. Because of her symptomatic valvular heart disease and the high perioperative risk (logistic EuroSCORE 18%), she was referred for transfemoral transcatheter aortic valve-in-valve implantation. Given the specific design ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Clinical utility of optical coherence tomography (OCT) in the optimisation of Absorb bioresorbable vascular scaffold deployment during percutaneous coronary intervention